5f8u: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
==Ligand occupancy in crystal structure of beta1-adrenergic receptor previously submitted by Huang et al== | ==Ligand occupancy in crystal structure of beta1-adrenergic receptor previously submitted by Huang et al== | ||
<StructureSection load='5f8u' size='340' side='right' caption='[[5f8u]], [[Resolution|resolution]] 3.35Å' scene=''> | <StructureSection load='5f8u' size='340' side='right' caption='[[5f8u]], [[Resolution|resolution]] 3.35Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[5f8u]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5F8U OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5F8U FirstGlance]. <br> | <table><tr><td colspan='2'>[[5f8u]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Melga Melga]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5F8U OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5F8U FirstGlance]. <br> | ||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=P32:4-{[(2S)-3-(TERT-BUTYLAMINO)-2-HYDROXYPROPYL]OXY}-3H-INDOLE-2-CARBONITRILE'>P32</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=P32:4-{[(2S)-3-(TERT-BUTYLAMINO)-2-HYDROXYPROPYL]OXY}-3H-INDOLE-2-CARBONITRILE'>P32</scene></td></tr> | ||
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4gpo|4gpo]]</td></tr> | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4gpo|4gpo]]</td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5f8u FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5f8u OCA], [http://pdbe.org/5f8u PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5f8u RCSB], [http://www.ebi.ac.uk/pdbsum/5f8u PDBsum]</span></td></tr> | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">ADRB1 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9103 MELGA])</td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5f8u FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5f8u OCA], [http://pdbe.org/5f8u PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5f8u RCSB], [http://www.ebi.ac.uk/pdbsum/5f8u PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5f8u ProSAT]</span></td></tr> | |||
</table> | </table> | ||
== Function == | == Function == | ||
| Line 18: | Line 20: | ||
</div> | </div> | ||
<div class="pdbe-citations 5f8u" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 5f8u" style="background-color:#fffaf0;"></div> | ||
==See Also== | |||
*[[Adrenergic receptor|Adrenergic receptor]] | |||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
[[Category: Melga]] | |||
[[Category: Leslie, A G.W]] | [[Category: Leslie, A G.W]] | ||
[[Category: Tate, C G]] | [[Category: Tate, C G]] | ||
Revision as of 09:04, 8 March 2018
Ligand occupancy in crystal structure of beta1-adrenergic receptor previously submitted by Huang et alLigand occupancy in crystal structure of beta1-adrenergic receptor previously submitted by Huang et al
Structural highlights
Function[ADRB1_MELGA] Beta-adrenergic receptors mediate the catecholamine-induced activation of adenylate cyclase through the action of G proteins. This receptor binds epinephrine and norepinephrine with approximately equal affinity. Publication Abstract from PubMedG protein-coupled receptors (GPCRs) mediate transmembrane signaling. Before ligand binding, GPCRs exist in a basal state. Crystal structures of several GPCRs bound with antagonists or agonists have been solved. However, the crystal structure of the ligand-free basal state of a GPCR, the starting point of GPCR activation and function, had not yet been determined. Here we report the X-ray crystal structure of the ligand-free basal state of a GPCR in a lipid membrane-like environment. Oligomeric turkey beta1-adrenergic receptors display two dimer interfaces. One interface involves the transmembrane domain (TM) 1, TM2, the C-terminal H8 and extracellular loop 1. The other interface engages residues from TM4, TM5, intracellular loop 2 and extracellular loop 2. Structural comparisons show that this ligand-free state is in an inactive conformation. This provides the structural basis of GPCR dimerization and oligomerization. Crystal structure of oligomeric beta1-adrenergic G protein-coupled receptors in ligand-free basal state.,Huang J, Chen S, Zhang JJ, Huang XY Nat Struct Mol Biol. 2013 Apr;20(4):419-25. doi: 10.1038/nsmb.2504. Epub 2013 Feb, 24. PMID:23435379[1] From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. See AlsoReferences
|
| ||||||||||||||||||||